Publications by authors named "Eden A Kemal"
J Neuroimmunol
February 2024
Article Synopsis
- Anti-CD20 therapies highlight the role of B cells in Multiple Sclerosis (MS), but the specifics of how they contribute to the disease are still unclear.
- Inflammation in MS leads to the accumulation of B cells in the meninges near demyelinating lesions, but their function and response to treatment remain unstudied.
- In a study involving mice, it was found that anti-CD20 therapy led to a delayed depletion of meningeal B cells, suggesting that the effect is indirect and linked to the turnover of these cells rather than direct access by the therapy.
